Non-allosteric inhibition of enolase 1 sensitizes triple-negative breast cancer for checkpoint inhibitors

被引：0
|
作者：
Tailor, Dhanir
Garcia-Marques, Fernando Jose
Bermudez, Abel
Li, Wenqi
Dheeraj, Arpit
Pitteri, Sharon J.
Malhotra, Sanjay V.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-5935
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5935
引用
收藏
页数：2
相关论文
共 50 条
  • [31] PARP Inhibitors in the Treatment of Triple-Negative Breast Cancer
    Jill J. J. Geenen
    Sabine C. Linn
    Jos H. Beijnen
    Jan H. M. Schellens
    Clinical Pharmacokinetics, 2018, 57 : 427 - 437
  • [32] A real-world study of immune checkpoint inhibitors in advanced triple-negative breast cancer
    Zhang, Zheng
    Zhang, Yadi
    Liu, Chuanling
    Shao, Jiakang
    Chen, Yimeng
    Zhu, Yimin
    Zhang, Li
    Qin, Boyu
    Kong, Ziqing
    Wang, Xixi
    Wang, Yutong
    Huang, Deqin
    Liu, Liqun
    Zhou, Yuxin
    Tao, Ran
    Yang, Zengjie
    Liu, Mei
    Zhao, Weihong
    CANCER INNOVATION, 2023, 2 (03): : 172 - 180
  • [33] Repression of phosphoglycerate dehydrogenase sensitizes triple-negative breast cancer to doxorubicin
    Xia Zhang
    Weijun Bai
    Cancer Chemotherapy and Pharmacology, 2016, 78 : 655 - 659
  • [34] Metformin sensitizes triple-negative breast cancer to histone deacetylase inhibitors by targeting FGFR4
    Gu, Zhangyuan
    Ye, Fugui
    Luo, Hong
    Li, Xiaoguang
    Gong, Yue
    Mao, Shiqi
    Jia, Xiaoqing
    Han, Xiangchen
    Han, Boyue
    Fu, Yun
    Cheng, Xiaolin
    Li, Jiejing
    Shao, Zhiming
    Wen, Peizhen
    Hu, Xin
    Zhuang, Zhigang
    JOURNAL OF BIOMEDICAL SCIENCE, 2025, 32 (01)
  • [35] PELP1 inhibition enhances the therapeutic efficacy of topoisomerase inhibitors in triple-negative breast cancer
    Nassar, Khaled Mohamed
    Sanchez, John R.
    Panneerdoss, Durga Meenakshi
    Ebrahimi, Behnam
    Xue, Yang
    Pratap, Uday P.
    Alejo, Salvador C.
    Sareddy, Gangadhara R.
    Viswanadhapalli, Suryavathi
    Vadlamudi, Ratna K.
    CANCER RESEARCH, 2024, 84 (06)
  • [36] Inhibition of triple negative breast cancer metastasis via Enolase-1 modulation
    Tailor, Dhanir
    Dheeraj, Arpit
    Garcia-Marques, Fernando Jose
    Pandrala, Mallesh
    Bermudez, Abel
    Pitteri, Sharon
    Malhotra, Sanjay V.
    CANCER RESEARCH, 2022, 82 (12)
  • [37] Role of mTOR inhibition in triple-negative breast cancer
    Massihnia, Daniela
    Bronte, Giuseppe
    Castiglia, Marta
    Barraco, Nadia
    Cangemi, Antonina
    Perez, Alessandro
    Fanale, Daniele
    Pantuso, Gianni
    Vieni, Salvatore
    Calo, Valentina
    Rolfo, Christian D.
    Bazan, Viviana
    Russo, Antonio
    CANCER RESEARCH, 2016, 76
  • [38] Lipogenesis inhibition in triple-negative breast cancer (TNBC)
    Giro-Perafita, Ariadna
    Palomeras, Sonia
    Polonio, Emma
    Ciurana, Joaquim
    Vinas, Gemma
    Puig, Teresa
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2017, 40 : S58 - S58
  • [39] Functional inhibition of the RNA-binding protein HuR sensitizes triple-negative breast cancer to chemotherapy
    Wei, Lanjing
    Zhang, Qi
    Zhong, Cuncong
    He, Lily
    Zhang, Yuxia
    Armaly, Ahlam M. M.
    Aube, Jeffrey
    Welch, Danny R. R.
    Xu, Liang
    Wu, Xiaoqing
    MOLECULAR ONCOLOGY, 2023, 17 (10) : 1962 - 1980
  • [40] Functional inhibition of the RNA-binding protein HuR sensitizes triple-negative breast cancer to chemotherapy
    Wei, Lanjing
    Zhang, Qi
    Zhong, Cuncong
    Aube, Jeffrey
    Welch, Danny
    Wu, Xiaoqing
    Xu, Liang
    CANCER RESEARCH, 2023, 83 (07)
12345